Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Guideline
Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on the treatment of multidrug-resistant TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB.

Author:

American Thoracic Society

Topic:

Treatment- TB Disease

Related Materials

2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar

The 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis webinar provides an overview of the guidelines development process, key changes in recommendations, and the evidence supporting the changes.

Webinar

Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines: Caveats and Controversies

This webinar provides an overview of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines and practical tips for implementation. Case studies are also presented.

Webinar

Guidelines for the Clinical and Operational Management of Drug-Resistant Tuberculosis

Based on The Union's 93-years of working in the field, the new guide tackles the challenges of fulfilling each patient's potential for cure from both the clinician's and the programme manager's perspective.

Guideline

Global resources for the prevention,
management, and elimination of TB.